Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-04-17 @ 6:29 AM
Study NCT ID:
NCT00232050
Status:
COMPLETED
Last Update Posted:
2011-10-25
First Post:
2005-10-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Omalizumab in Moderate to Severe Bronchial Asthma
Sponsor:
Novartis
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CIGE025A1304
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |